US Patent Issued to Kumquat Biosciences on Dec. 23 for "1,2,5-thiadiazolidin-3-one 1,1-dioxide containing compounds and uses thereof" (California Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,464, issued on Dec. 23, was assigned to Kumquat Biosciences Inc. (San Diego).

"1,2,5-thiadiazolidin-3-one 1,1-dioxide containing compounds and uses thereof" was invented by Liansheng Li (San Diego) and Pingda Ren (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds and pharmaceutical compositions comprising the same. The compounds, pharmaceutical compositions thereof, and methods of using the same have a range of utilities as therapeutics, diagnostics, and research tools. The subject compositions and methods are particularly useful for potentiating immune response and/or for treating cancer and other di...